crashrocketgame| Microcore Biotech (688321.SH): The prices of sidarabenide and sitlitat sodium are expected to remain relatively stable in the next two years

Gelonghui May 17 丨 Microchip Biology (688321crashrocketgame.SH) recently stated in a survey by institutional investors that the current PTCL indication of Sidabenamine has been included in the national medical insurance for the fourth time, and the DLBCL indication has been approved at the end of April, which is in line with the conditions for participating in the national medical insurance talks in the second half of this year. New indications are included in medical insurance. How to maintain drug accessibility and the company's profitability through medical insurance negotiations is the company's ongoing work. The company expects that in the next two years, Sidabenamide and Sitrigley will increasecrashrocketgameThe price of sodium will remain relatively stable.